Semaglutide
11 research papers indexed
Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes
0
JAMA Internal Medicine
·2026Clinical TrialHumanHeart failure outcomes in T2D with ASCVD/CKD
Marso 2016 — SUSTAIN-6 CVOT Semaglutide
0
New England Journal of Medicine
·2016RCTHumanCV outcomes in T2DSourceRCT
Improved quality of life with semaglutide in schizophrenia: Secondary analyses from a randomized controlled trial
0
Schizophrenia Research
·2026Clinical TrialHumanSchizophrenia spectrum disorder with obesity
McGuire 2025 — SOUL CVOT Oral Semaglutide
0
New England Journal of Medicine
·2025RCTHumanCV outcomes in T2DSourceRCT
Lincoff 2023 — SELECT CVOT Semaglutide
0
New England Journal of Medicine
·2023RCTHumanCV outcomes in obesity without diabetesSourceRCT
Perkovic 2024 — FLOW Kidney CVOT Semaglutide
0
New England Journal of Medicine
·2024RCTHumanCKD with T2DSourceRCT
Wilding 2021 — STEP 1 Semaglutide Pivotal
0
New England Journal of Medicine
·2021RCTHumanObesity without diabetesSourceRCT
Clinical Trial: Semaglutide Versus Placebo in NIT-Assessed MASH-A Multicenter Randomised Placebo-Controlled Trial (SAMARA)
0
Alimentary Pharmacology & Therapeutics
·2026Clinical TrialHumanAt-risk MASH (metabolic dysfunction-associated steatohepatitis)
Sanyal 2025 — ESSENCE MASH Semaglutide
0
New England Journal of Medicine
·2025RCTHumanMASH with fibrosis stage 2 or 3SourceRCT
Bimagrumab plus semaglutide alone or in combination for the treatment of obesity
0
Nature Medicine
·2026Clinical TrialHumanObesity
Semaglutide Effects on Insulin Sensitivity and β-Cell Function in Patients With Schizophrenia
0
Diabetes Care
·2026Clinical TrialHumanSchizophrenia spectrum disorder with obesity